These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9178456)

  • 1. Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus.
    Tang YW; Neuzil KM; Fischer JE; Robinson FW; Parker RA; Graham BS
    Vaccine; 1997; 15(6-7):597-602. PubMed ID: 9178456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine pattern is solely influenced by priming vaccine but immunity and disease by both priming and boosting vaccines in mice challenged with respiratory syncytial virus.
    Tang YW
    Virus Res; 2004 Jan; 99(1):81-7. PubMed ID: 14687950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abundant IFN-gamma production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease.
    Spender LC; Hussell T; Openshaw PJ
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1751-8. PubMed ID: 9680139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced humoral and CD8+ T cell immunity in mice vaccinated by DNA vaccine against human respiratory syncytial virus through targeting the encoded F protein to dendritic cells.
    Hua Y; Jiao YY; Ma Y; Peng XL; Fu YH; Zhang XJ; Zheng YB; Zheng YP; Hong T; He JS
    Int Immunopharmacol; 2017 May; 46():62-69. PubMed ID: 28259002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virus-Like Particle Vaccine Containing the F Protein of Respiratory Syncytial Virus Confers Protection without Pulmonary Disease by Modulating Specific Subsets of Dendritic Cells and Effector T Cells.
    Kim KH; Lee YT; Hwang HS; Kwon YM; Kim MC; Ko EJ; Lee JS; Lee Y; Kang SM
    J Virol; 2015 Nov; 89(22):11692-705. PubMed ID: 26355098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus.
    Graham BS; Henderson GS; Tang YW; Lu X; Neuzil KM; Colley DG
    J Immunol; 1993 Aug; 151(4):2032-40. PubMed ID: 8345194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice.
    Tang YW; Graham BS
    J Clin Invest; 1997 May; 99(9):2183-91. PubMed ID: 9151790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of CD4+ and CD8+ T lymphocyte subsets to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens.
    Dearman RJ; Moussavi A; Kemeny DM; Kimber I
    Immunology; 1996 Dec; 89(4):502-10. PubMed ID: 9014813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of IFN in respiratory syncytial virus pathogenesis.
    Durbin JE; Johnson TR; Durbin RK; Mertz SE; Morotti RA; Peebles RS; Graham BS
    J Immunol; 2002 Mar; 168(6):2944-52. PubMed ID: 11884466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T lymphocyte activity and cytokine expression in calves vaccinated with formalin-inactivated bovine respiratory syncytial virus prior to challenge.
    Woolums AR; Gunther RA; McArthur-Vaughan K; Anderson ML; Omlor A; Boyle GA; Friebertshauser KE; McInturff PS; Gershwin LJ
    Comp Immunol Microbiol Infect Dis; 2004 Jan; 27(1):57-74. PubMed ID: 14656542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment.
    Plotnicky-Gilquin H; Huss T; Aubry JP; Haeuw JF; Beck A; Bonnefoy JY; Nguyen TN; Power UF
    Virology; 1999 May; 258(1):128-40. PubMed ID: 10329575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of STAT6 during vaccination with formalin-inactivated RSV prevents induction of Th2-cell-biased airway disease.
    Srinivasa BT; Fixman ED; Ward BJ
    Eur J Immunol; 2014 Aug; 44(8):2349-59. PubMed ID: 24796717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular Immune Correlates Preventing Disease Against Respiratory Syncytial Virus by Vaccination with Virus-Like Nanoparticles Carrying Fusion Proteins.
    Lee YT; Ko EJ; Kim KH; Hwang HS; Lee Y; Kwon YM; Kim MC; Lee YN; Jung YJ; Kang SM
    J Biomed Nanotechnol; 2017 Jan; 13(1):84-98. PubMed ID: 29302248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity.
    Tang YW; Graham BS
    J Infect Dis; 1995 Sep; 172(3):734-8. PubMed ID: 7658066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual proinflammatory and antiviral properties of pulmonary eosinophils in respiratory syncytial virus vaccine-enhanced disease.
    Su YC; Townsend D; Herrero LJ; Zaid A; Rolph MS; Gahan ME; Nelson MA; Rudd PA; Matthaei KI; Foster PS; Dent L; Tripp RA; Lee J; Simson L; Mahalingam S
    J Virol; 2015 Feb; 89(3):1564-78. PubMed ID: 25410867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine responses of bovine dendritic cells and T cells following exposure to live or inactivated bovine respiratory syncytial virus.
    Werling D; Collins RA; Taylor G; Howard CJ
    J Leukoc Biol; 2002 Aug; 72(2):297-304. PubMed ID: 12149420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.
    Plotnicky-Gilquin H; Cyblat-Chanal D; Aubry JP; Champion T; Beck A; Nguyen T; Bonnefoy JY; Corvaïa N
    J Virol; 2002 Oct; 76(20):10203-10. PubMed ID: 12239295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine expression in respiratory syncytial virus-infected mice as measured by quantitative reverse-transcriptase PCR.
    Deng X; Li H; Tang YW
    J Virol Methods; 2003 Feb; 107(2):141-6. PubMed ID: 12505627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection against respiratory syncytial virus infection by DNA immunization.
    Li X; Sambhara S; Li CX; Ewasyshyn M; Parrington M; Caterini J; James O; Cates G; Du RP; Klein M
    J Exp Med; 1998 Aug; 188(4):681-8. PubMed ID: 9705950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
    Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
    J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.